CSL Limited (CMXHF PINK) stock market data APIs
$153.459
-2.09(-1.4%)
as of July 3, 2025
Try our APIs with
free plan!
CSL Limited Financial Data Overview
Price chart is built with
Anychart
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Prev. Close
153.459
Open
151.3677
High
157.5335
Low
151.3677
52 wk Range
137.4-208.3113
Market Cap
77 309 M
P/E Ratio
28.0239
Shares Outstanding
484 M
Revenue
15 230 M
EPS
0.62
Dividends (Yield)
0.0167
Beta
0.351
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CSL Limited data using free add-ons & libraries
Get CSL Limited Fundamental Data
CSL Limited Fundamental data includes:
- Net Revenue: 15 230 M
- EBITDA: 4 824 M
- Earnings Per Share: 5
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CSL Limited News
New
ALKS or CSLLY: Which Is the Better Value Stock Right Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Alkermes (ALKS) and CSL Limited Sponsored ADR (CSLLY). But which of these two stocks pre...
CSL to replace Bavarian Nordic in Valneva’s vaccine deal for Germany
[Tip of fountain pen writing] Martin Barraud * French biotech Valneva SE (NASDAQ:VALN [https://seekingalpha.com/symbol/VALN]) announced Thursday a partnership with Australian company CSL Limited (O...
Is There An Opportunity With CSL Limited's (ASX:CSL) 39% Undervaluation?
Key Insights The projected fair value for CSL is AU$391 based on 2 Stage Free Cash Flow to Equity Current share price of AU$239 suggests CSL is potentially 39% undervalued Analyst price target for CS...
New CDC vaccine experts to vote on mercury-based preservative in flu shots
[CDC campus] A newly appointed CDC advisory panel of vaccine experts is scheduled to meet later this month to vote on recommendations for flu shots containing a mercury-based preservative, according ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
